Global North America Medical Imaging AI Market Analysis, Opportunities and Forecast 2024-2032
North America Medical Imaging AI market valued at $1.5B in 2023, projected to reach $10.77B by 2032 at 24.5% CAGR.
$1.5B
$10.8B
24.5%
North America
Executive Summary
The North America Medical Imaging AI market was valued at $1.5 billion in 2023 and is projected to reach $10.77 billion by 2032, growing at a CAGR of 24.5%. North America commands approximately 45% of the global medical imaging AI market, driven by advanced healthcare infrastructure, high radiology volumes, and strong regulatory pathways. Key growth is fueled by AI-assisted diagnostics in radiology, cardiology, and oncology. Leading players include NVIDIA, Siemens Healthineers, and Aidoc. Investment opportunities are strongest in cloud-based imaging platforms and point-of-care AI solutions.
Key Highlights
Market projected to grow from $1.5B to $10.77B at 24.5% CAGR through 2032
CT imaging AI leads modality segmentation with 25% market share
Radiology applications dominate end-use demand accounting for 30% of segment
Market Overview
Market Context
The North America Medical Imaging AI market is in a high-growth phase driven by radiologist shortages, rising chronic disease burden, and accelerating FDA approvals for AI-based diagnostic tools. Hospitals and diagnostic centers are primary adopters, with cloud-based deployment models gaining preference.
The North America Medical Imaging AI market is experiencing rapid growth, driven by rising imaging volumes, radiologist shortages, and FDA-cleared AI algorithms. The market reached $1.5 billion in 2023 and is set to exceed $10.77 billion by 2032. Radiology and cardiology applications dominate adoption.
Market Stage
High growth
Adoption Level
Growing
Key Trends
Market Forecast & Data
Base Year (2023)
$1.5B
Forecast (2032)
$10.8B
CAGR (2024-2032)
24.5%
| Year | Market size ($ Billion) |
|---|---|
| 2023Base year | $1.50B |
| 2024 | $1.87B |
| 2025 | $2.33B |
| 2026 | $2.89B |
| 2027 | $3.60B |
| 2028 | $4.49B |
| 2029 | $5.59B |
| 2030 | $6.95B |
| 2031 | $8.66B |
| 2032 | $10.78B |
The market is forecast to grow ninefold from $1.5B to $10.77B by 2032. CT and radiology segments will lead growth. The United States will remain the dominant market while ambulatory care settings represent the fastest-growing end-user segment.
| Region | Market share | Growth rate | Largest market |
|---|---|---|---|
| North America | 45.0% | 24.5% | United States |
| Europe | 30.0% | 22.0% | Germany |
| Asia Pacific | 25.0% | 28.0% | China |
North America
#1Largest market: United States
Europe
#2Largest market: Germany
Market Dynamics
- Increasing radiologist shortage driving demand for AI-assisted diagnostics
- Rising imaging volumes due to aging population and chronic disease prevalence
- FDA expedited clearance pathways enabling faster AI algorithm approvals
Market Segmentation
| Segment | Share |
|---|---|
| CTLargest segment driven by AI-powered detection of lung nodules, brain hemorrhages, and cardiac abnormalities. | 25.0% |
| MRIGrowing adoption of AI for cardiac MRI quantification and neuroimaging analysis. | 22.0% |
| X-rayWidely deployed AI for chest X-ray screening and fracture detection in emergency settings. | 20.0% |
| UltrasoundEmerging segment with AI-guided point-of-care ultrasound gaining traction in primary care. | 15.0% |
| MammographyAI-assisted breast cancer screening gaining regulatory approvals and clinical adoption. | 10.0% |
| PETAI-enhanced PET imaging for oncology staging and treatment response monitoring. | 8.0% |
| Total | 100.0% |
| Segment | Share |
|---|---|
| RadiologyDominant application area with broad AI deployment across chest, abdominal, and neuroimaging. | 30.0% |
| OncologyAI-driven tumor detection, segmentation, and treatment monitoring across multiple modalities. | 22.0% |
| CardiologyAI for cardiac imaging including ejection fraction measurement and coronary artery analysis. | 20.0% |
| NeurologyStroke detection, brain tumor analysis, and neurodegenerative disease screening applications. | 15.0% |
| OrthopedicsAI-assisted fracture detection and musculoskeletal imaging analysis gaining clinical traction. | 13.0% |
| Total | 100.0% |
By End User
- Hospitals
- Diagnostic Centers
- Research Institutes
Regional Analysis
North America
Lead: United StatesLargest market globally driven by advanced healthcare IT infrastructure, high imaging volumes, and strong FDA pipeline.
Europe
Lead: GermanyGrowing adoption supported by EU MDR framework and increasing AI integration in radiology departments.
Asia Pacific
Lead: ChinaFastest-growing region driven by massive imaging demand, government healthcare digitization initiatives, and AI startup proliferation.
Country-Level Analysis
| Country | Share | Growth |
|---|---|---|
| United States | 40.0% | +24.5% |
| Germany | 15.0% | +21.0% |
| China | 18.0% | +30.5% |
Competitive Landscape
NVIDIA
United States
Dominates medical imaging AI infrastructure through Clara platform and GPU-accelerated computing for diagnostic imaging.
Global leader in GPU-accelerated computing providing the Clara medical imaging AI platform for radiology, pathology, and drug discovery applications.
Aidoc
Israel
Fast-growing AI startup with multiple FDA clearances for acute findings in radiology including pulmonary embolism and intracranial hemorrhage.
Leading clinical AI company with multiple FDA clearances focused on detecting acute abnormalities in radiology workflows.
Arterys
United States
Specializes in cloud-native cardiac and lung imaging AI with FDA-cleared quantification tools for MRI and CT.
Also profiled
Siemens Healthineers
Major medical technology company integrating AI-powered imaging solutions across CT, MRI, and molecular imaging platforms globally.
Recent Developments
Launched Clara AI platform 4.0 with expanded support for 50+ imaging models and federated learning capabilities
Received FDA 510(k) clearance for AI algorithm detecting collapsed lung conditions, expanding its radiology portfolio to 15+ clearances
Regulatory Landscape
Research Methodology
Primary research
- Expert interviews with radiologists and hospital IT directors
- Surveys of healthcare technology procurement officers
Secondary research
- Industry analyst reports from IDC and Gartner
- Company financial filings and investor presentations
Validation: Triangulation method
Strategic Takeaways
The 24.5% CAGR presents strong VC and PE opportunities in diagnostic AI startups and imaging infrastructure plays.
Prioritize cloud-native AI platforms and radiology workflow integration to capture growing hospital demand.
Regulatory frameworks like FDA SaMD are enabling faster market entry while ensuring clinical safety standards.
Interoperability with existing PACS and EHR systems is critical for successful market penetration.
Frequently Asked Questions
Related research
Reports in the same field, each with its base-year figure and the growth rate it is published at.
- Medical ImagingGlobal Medical Imaging AI Market$1.4B · 22.5% CAGR
- Medical ImagingGlobal United States Medical Imaging AI Market$1.1B · 27.5% CAGR
- Medical ImagingGlobal Europe Medical Imaging AI Market$0.9B · 26.5% CAGR
- Medical ImagingGlobal Asia Pacific Medical Imaging AI Market$2.4B · 22.5% CAGR
- Medical DevicesGlobal North America Wearable Medical Devices Market$16.5B · 13.5% CAGR
- BiotechnologyGlobal North America Gene Therapy Market$10.0B · 30% CAGR